JP2022545078A5 - - Google Patents
Info
- Publication number
- JP2022545078A5 JP2022545078A5 JP2022510802A JP2022510802A JP2022545078A5 JP 2022545078 A5 JP2022545078 A5 JP 2022545078A5 JP 2022510802 A JP2022510802 A JP 2022510802A JP 2022510802 A JP2022510802 A JP 2022510802A JP 2022545078 A5 JP2022545078 A5 JP 2022545078A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- positive
- population
- induction medium
- precursor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1911953.6 | 2019-08-20 | ||
| GBGB1911953.6A GB201911953D0 (en) | 2019-08-20 | 2019-08-20 | T cell production fram RAG inacivated iPSCs |
| PCT/EP2020/073400 WO2021032852A1 (en) | 2019-08-20 | 2020-08-20 | T cell production from rag inactivated ipscs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022545078A JP2022545078A (ja) | 2022-10-25 |
| JP2022545078A5 true JP2022545078A5 (enExample) | 2023-08-18 |
Family
ID=68099394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022510802A Pending JP2022545078A (ja) | 2019-08-20 | 2020-08-20 | ＲＡＧが不活性化されたｉＰＳＣからのＴ細胞生産 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220275332A1 (enExample) |
| EP (1) | EP4017968A1 (enExample) |
| JP (1) | JP2022545078A (enExample) |
| KR (1) | KR20220044844A (enExample) |
| CN (1) | CN114269904A (enExample) |
| AU (1) | AU2020334258A1 (enExample) |
| BR (1) | BR112022003093A2 (enExample) |
| CA (1) | CA3150429A1 (enExample) |
| GB (1) | GB201911953D0 (enExample) |
| IL (1) | IL290604A (enExample) |
| MX (1) | MX2022001959A (enExample) |
| WO (1) | WO2021032852A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2022001961A (es) * | 2019-08-20 | 2022-03-11 | Adaptimmune Ltd | Medio de cultivo para induccion de hematopoyesis. |
| GB202006903D0 (en) * | 2020-05-11 | 2020-06-24 | Adaptimmune Ltd | Modified iPSCs |
| WO2022059780A1 (ja) * | 2020-09-18 | 2022-03-24 | サイアス株式会社 | ｉＰＳ細胞を介する再生Ｔ細胞の製造方法 |
| GB202111169D0 (en) * | 2021-08-03 | 2021-09-15 | Adaptimmune Ltd | Methods of T cell production |
| CN114517176B (zh) * | 2022-01-27 | 2022-12-02 | 广东普罗凯融生物医药科技有限公司 | 一种将ips细胞诱导成nk细胞的试剂盒及其应用方法 |
| GB202205572D0 (en) | 2022-04-14 | 2022-06-01 | Adaptimmune Ltd | Engineered T cells |
| GB202208545D0 (en) | 2022-06-10 | 2022-07-27 | Adaptimmune Ltd | Production of immune cells |
| GB202318950D0 (en) | 2023-12-12 | 2024-01-24 | Adaptimmune Ltd | Production of immune cells |
| CN118421559B (zh) * | 2024-07-04 | 2024-09-27 | 成都赛济元生物医药有限公司 | 定向分化淋巴造血前体细胞的小分子组合、试剂盒及方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012061075A2 (en) * | 2010-10-25 | 2012-05-10 | The Regents Of The University Of California | Hiv resistant and functional hematopoietic stem/progenitor cells and macrophages from induced pluripotent stem cells |
| SG11201507275TA (en) * | 2013-03-13 | 2015-10-29 | Wisconsin Alumni Res Found | Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions |
| SG10201900323SA (en) * | 2014-07-18 | 2019-02-27 | Univ Kyoto | Method for inducing t cells for cell-based immunotherapy from pluripotent stem cells |
| AU2016344135A1 (en) * | 2015-10-27 | 2018-06-14 | Board Of Regents, The University Of Texas System | Engineering of humanized car T-cells and platelets by genetic complementation |
| WO2017078807A1 (en) * | 2015-11-04 | 2017-05-11 | Fate Therapeutics, Inc. | Methods and compositions for inducing hematopoietic cell differentiation |
| JP2019080491A (ja) * | 2016-03-16 | 2019-05-30 | 国立大学法人京都大学 | 免疫細胞療法用ｎｙ−ｅｓｏ１抗原特異的ｔ細胞の誘導方法 |
| JP2021513839A (ja) * | 2018-02-16 | 2021-06-03 | カイト ファーマ インコーポレイテッドＫｉｔｅ Ｐｈａｒｍａ， Ｉｎｃ | 改変された多能性幹細胞並びに製造方法及び使用方法 |
| MX2022001961A (es) * | 2019-08-20 | 2022-03-11 | Adaptimmune Ltd | Medio de cultivo para induccion de hematopoyesis. |
-
2019
- 2019-08-20 GB GBGB1911953.6A patent/GB201911953D0/en not_active Ceased
-
2020
- 2020-08-20 CA CA3150429A patent/CA3150429A1/en active Pending
- 2020-08-20 CN CN202080059218.8A patent/CN114269904A/zh active Pending
- 2020-08-20 EP EP20761196.3A patent/EP4017968A1/en not_active Withdrawn
- 2020-08-20 JP JP2022510802A patent/JP2022545078A/ja active Pending
- 2020-08-20 KR KR1020227009005A patent/KR20220044844A/ko active Pending
- 2020-08-20 WO PCT/EP2020/073400 patent/WO2021032852A1/en not_active Ceased
- 2020-08-20 AU AU2020334258A patent/AU2020334258A1/en not_active Abandoned
- 2020-08-20 US US17/630,883 patent/US20220275332A1/en not_active Abandoned
- 2020-08-20 BR BR112022003093A patent/BR112022003093A2/pt unknown
- 2020-08-20 MX MX2022001959A patent/MX2022001959A/es unknown
-
2022
- 2022-02-14 IL IL290604A patent/IL290604A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022545415A5 (enExample) | ||
| JP2022545782A5 (enExample) | ||
| JP7613712B2 (ja) | 抗原特異的ｔ細胞の製造方法 | |
| US12024717B2 (en) | Method for reconstructing immune function using pluripotent stem cells | |
| KR102598351B1 (ko) | 만능 줄기 세포를 hla 동형 접합 면역 세포로 직접 분화시키기 위한 방법 | |
| JP2021191294A (ja) | 多能性幹細胞を用いた免疫機能再建法 | |
| KR20180063333A (ko) | 면역 세포로의 만능 줄기 세포의 지정된 분화 방법 | |
| JP2019526266A (ja) | 人工多能性幹細胞由来の免疫細胞 | |
| WO2009034172A1 (en) | Enhancing the t-cells stimulatory capacity of human antigen presenting cells and their use in vaccination | |
| US12421496B2 (en) | Method for producing natural killer cell and use thereof | |
| SG10202106515SA (en) | Methods and kits for generating mimetic innate immune cells from pluripotent stem cells | |
| KR20150126943A (ko) | 규정된 조건하에서 인간 만능성 줄기 세포의 조혈내피세포 분화를 위한 방법 및 재료 | |
| CN102329769A (zh) | 一种获得造血干细胞的方法 | |
| JP2024507472A5 (enExample) | ||
| Martin et al. | Differences in lymphocyte developmental potential between human embryonic stem cell and umbilical cord blood–derived hematopoietic progenitor cells | |
| JP2022545416A5 (enExample) | ||
| US20150087065A1 (en) | Method for generation of conditionally immortalized hematopoietic progenitor cell lines with multiple lineage potential | |
| JP2023502318A (ja) | 細胞を再プログラム化して形質細胞様樹状細胞またはｉ型インターフェロン産生細胞に変換する組成物、その方法および用途 | |
| CN115087732B (zh) | 来自人T细胞来源的iPS细胞的细胞毒性T细胞 | |
| Kawai et al. | Feeder-free generation of CD4 single-positive helper T cells from human iPSCs via stage-specific modulation of Notch and TCR Signaling | |
| TW202235094A (zh) | 經回春的ｔ細胞之製造方法、包含彼之組成物、及彼之使用方法 | |
| JP2018093823A (ja) | 未分化幹細胞除去剤及び未分化幹細胞除去方法 | |
| RU2022107097A (ru) | Получение т-клеток из ipsc с инактивированным rag | |
| RU2022107099A (ru) | Культуральная среда для гемопоэтической индукции | |
| JP2023554441A (ja) | 細胞リプログラミングのための組成物、構築物及びベクター |